Taiga Professional A320 - 60 Caps
Finally Back in stock....
Conifer trees remain evergreen at -50 degrees celcius to +40 degrees celcius. Scientists in Russia have researched this phenomenal endurance for decades. "Live elements" within these trees were successfully extracted as an unchanged natural complex. Today they are known as Bioeffectives®.
Taiga Professional A320 is based on Conifer Green Needle Complex (CGNC), the first Bioeffective, a potent, unique antioxidant complex extracted from selected species of fresh conifer green needles from the Siberian TAIGA.
It contains a vast spectrum of concentrated natural compounds such as chlorophyll, carotenoids (lutein, zeaxanthin, beta carotene), polypropenols, fatty and resin acids.
Each TAIGA Professional A320 capsule contains the equivalent of 6400 mg of fresh conifer needles.
Dosage:
Adults: Take one capsule twice daily before meals or as directed by your healthcare professional.
Nutritional Information
Active ingredient: Conifer Green Needle Complex (Bioeffective A) 320 mg
Contains soya oil
Studies highlight the following conditions / results
A 2016 observational pilot study investigated CGNC's effects on patients with precancerous gastric lesions.
The results were encouraging:
- 92.3% of CGNC-treated patients showed regression of dyspeptic symptoms
- 57.1% experienced eradication of H. pylori infection
- 92.3% had reduced endoscopic signs of gastritis
- 57.7% showed increased pepsinogen-pepsin in gastric juice
- 46.2% demonstrated regression of intestinal metaplasia
- 53.8% had decreased lymphoplasmacytic infiltration
Antimicrobial Properties
- Suppressed H. pylori both in vitro and in vivo
- Effective against 83 bacterial strains and 16 Candida strains
- Demonstrated activity against Trichomonas vaginalis in vitro
A 2018 study found CGNC to be effective as an antimycotic against fluconazole- and ketoconazole-resistant Candida species, including C. albicans, C. glabrata, and C. krusei
Mechanism of Action
CGNC's gastrointestinal benefits are attributed to several components:
- Chlorophyll derivatives and phytoncide complex: antibacterial and antifungal activity
- Carotenoids: stimulate immune reactions against H. pylori
- Antioxidants: reduce inflammation and oxidative stress in gastric mucosa
Additional Benefits
- Improved stomach function in patients with chronic atrophic gastritis
- Increased production of hydrochloric acid and pepsin-pepsinogen in the stomach mucosa
- Enhanced endoscopic signs of precancerous changes
While these results are promising, larger randomised controlled trials are needed to confirm CGNC's efficacy in treating gastrointestinal issues. The current evidence suggests that CGNC may be a valuable complementary approach for supporting gastrointestinal health, particularly in cases of precancerous gastric lesions and H. pylori infection.
Studies highlighting Taiga effectiveness
https://www.hindawi.com/journals/ecam/2016/3848409/?fbclid=IwAR3JXdKyRPb0w7BeSuG4kH9OdHhXr3g2eLsB1XTw7mvJyxuEv_R-BHeuM20
https://pubmed.ncbi.nlm.nih.gov/28003849/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5149685/
https://journals.sagepub.com/doi/pdf/10.1177/1934578X1901400138
https://onlinelibrary.wiley.com/doi/10.1155/2016/3848409